As we know, the bcr-abl containing the first exon of bcr which includes a coiled-coil domain, Tyr177, SH2 binding domain and a serine/threonine kinase domain, is crucial to induce chronic-phase CML [36, 38–41]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.